The Patent Finder

BioAxone BioSciences, Inc.

Also on record
Records under this name other than the patents BioAxone BioSciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.

Showing 1 to 7 of 7 · Back to BioAxone BioSciences, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,491,692Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
Term ended
Term ended Feb 28, 2023 · USPTO record
Term endedTerm ended Feb 28, 2023USPTO record
US 6,855,688ADP-ribosyl transferase fusion proteins, pharmaceutical compositions, and methods of use
Term ended
Term ended Sep 25, 2022 · USPTO record
Term endedTerm ended Sep 25, 2022USPTO record
US 7,795,218ADP-ribosyl transferase fusion variant proteins
Formerly held
Lapsed on the fee record
Ended Sep 14, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 14, 2022USPTO record
US 7,910,554Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
Term ended
Ended no later than Apr 9, 2022 · USPTO record
Term endedEnded no later than Apr 9, 2022USPTO record
US 7,141,428Methods for making and delivering rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof
Term ended
Term ended Nov 8, 2021 · USPTO record
Term endedTerm ended Nov 8, 2021USPTO record
US 7,442,686Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions
Lapsed on the fee record
Ended Oct 28, 2020 · USPTO record
Lapsed on the fee recordEnded Oct 28, 2020USPTO record
US 7,169,783(+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
Term ended
Term ended Dec 10, 2018 · USPTO record
Term endedTerm ended Dec 10, 2018USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited